| Veno-occlusive disease in pediatric patients after hematopoietic stem cell transplantation: relevance of activated coagulation and fibrinolysis markers and natural anticoagulants. | |
| | |
MedLine Citation:
|
PMID: 21336167 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Prediction of veno-occlusive disease (VOD), its precise diagnosis, and treatment have been the subject of various studies, but still remain unclear. Our goal was to investigate the levels of activated coagulation and fibrinolysis markers and natural anticoagulants in pediatric patients with VOD after hematopoietic stem cell transplantation (HSCT). We investigated 47 pediatric patients: 20 with neuroblastoma, 17 with leukemias, and 10 with lymphomas and measured the values of antithrombin (AT), protein C (PC), fibrinogen (FI), thrombin AT complex, prothrombin fragments 1+2 (F1+2), and D-dimer from day -7 to day +30 post-HSCT. Patients were monitored for the occurrence of VOD, and it occurred in 10 patients at a median post-HSCT day of 17.5 (range: 2 to 28 d). In the VOD group, at baseline the levels of FI were significantly lower, and on days +7 and +14 a relevant difference existed in F1+2 levels. The levels of PC were significantly lower on day +14. Logistic multivariate regression analysis between the groups showed significantly different D-dimer levels on day +14. On day +30, the levels of PC, AT, and F1+2 were different between these 2 groups of patients. The levels of D-dimer and F1+2 were increased, and PC and FI decreased before the clinical onset of VOD. The parameter differences may have a predictive value in VOD onset, which makes them candidates to be routinely monitored in patients after HSCT. |
| | |
Authors:
|
Dragana Jevtic; Zeljko Zecevic; Dobrila Veljkovic; Violeta Dopsaj; Zoran Radojicic; Ivo Elezovic |
Related Documents
:
|
21931087 - Extended infrabrow excision blepharoplasty for dermatochalasis in asians. 21557237 - What faces reveal: impaired affect display in facial paralysis. 21149747 - Necrotizing and nonnecrotizing variants of herpetic uveitis with posterior segment invo... 21216547 - A clinical study of olfactory dysfunction in patients with mikulicz's disease. 12619187 - Gadolinium dimeglumine as a contrast agent for digital subtraction angiography: in vitr... 23117307 - Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of pediatric hematology/oncology Volume: 33 ISSN: 1536-3678 ISO Abbreviation: J. Pediatr. Hematol. Oncol. Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-03-23 Completed Date: 2011-06-02 Revised Date: 2011-10-06 |
Medline Journal Info:
|
Nlm Unique ID: 9505928 Medline TA: J Pediatr Hematol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 227-34 Citation Subset: IM |
Affiliation:
|
Bone Marrow Transplantation Unit and Coagulation Laboratory, Mother and Child Health Care Institute of Serbia Dr Vukan Cupic, Institute for Statistics, University of Belgrade, Belgrade, Serbia. drjevtic@beotel.rs |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Anticoagulants / blood* Blood Coagulation* Child Child, Preschool Female Fibrin Fibrinogen Degradation Products / analysis Fibrinolysis* Hematopoietic Stem Cell Transplantation / adverse effects* Hepatic Veno-Occlusive Disease / blood, etiology* Humans Infant Male Transplantation Conditioning |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Fibrin Fibrinogen Degradation Products; 0/fibrin fragment D |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Attitudes and practices of oncologists toward fertility preservation.
Next Document: Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases tr...